Valuation
26% of the score
100median 50
Embecta Corp. is valued at 7.1x its operating profit, including debt: cheap enough for full points.
60x
50x
35x
25x
18x
12x
8x
7.1x
Full points at 8x or less, none from 60xfull points
EMBCEmbecta Corp.
$3.35-66% 1Y
$3.35
$2.8952 weeks$14.20
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 64 out of 100, Above average
Today's price. Only valuation depends on it.
Above average. Embecta Corp. scores higher than 67% of the 2,291 companies Ryufin scores.
Carried by valuation and return on capital, held back by return on new capital and capital allocation.
Healthcare median 18 · all companies 54
Return on capital
18% of the score
100median 23
Over 4 years the business earned 33% a year after tax on the capital it uses.
2%
8%
15%
25%
33%
None at 2% or less, full points from 25%full points
4 years agolatest 27%
Return on new capital
16% of the score
0median 33
Over 6 years yearly profit fell by 22 cents for every dollar earned.
-5%
12%
-22%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score
37median 63
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 0.7% a year over 5 years: new shares
545%
-3%
0.7%
0 pointsfull points
Assets against salesAssets grew 8.5% a year, sales -1.9%
1212%
-2%
10%
0 pointsfull points
Cycle position
12% of the score
76median 63
Today's operating margin of 22% is 0.91x its normal 24%: close to its usual level. Normal is half the 6 year median, half the last four years, so a margin that has held is not taken for a peak.
2x
1.5x
1x
0.7x
0.9x
A trough earns points, a peak costs themfull points
6 years agonow 22%
Balance sheet
8% of the score
0median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDA4.6x a year of EBITDA
04.5x
0.5x
4.6x
0 pointsfull points
Earnings quality
6% of the score
94median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
Cash against profitOperating cash flow was 1.21x profit over 3 years
880.7x
1x
1.3x
1.2x
0 pointsfull points
AccrualsCash ran ahead of profit by 8.1% of assets
1008%
0%
-8%
-8.1%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. Where a criterion cannot be measured from the filings it is taken out and the remaining weights scale up; a company needs 60% of the weight covered, and always a price, to get a score.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.
Medical Instruments & Supplies
Ranks #3 of 21 by RyuScore